SiteRx, founded by Columbia Business School’s Seth Goodman, was named one of our most disruptive MBA startups of 2019.
Moons, 2018
MBA Founder: Alexander Clapp, INSEAD
Total Raised: $15 million
Latest Funding Round: $9M Late VC
Moons, based in Mexico City, provides dental services throughout Latin America, most notably 3D printed teeth aligners as an alternative to braces. Moons plans to expand to other dental, health and wellness services through the region. Its latest Series A funding round was in May 2022, and it has 13 investors with FJ Labs and Jacket River being the most recent.
TechCrunch named Moons one of its top 20 Y Combinator’s startups from its W20 Demo Day. Clapp is a co-founder and CEO.
Nilo Saúde, 2020
MBA Founder: Isadora Kimura, Stanford GSB
Total Raised: $12.9 million
Latest Funding Round: $11.2M Series A January 2022
Nilo Saúde is a healthtech with the mission to democratize healthcare access in Brazil. Nilo is building an integrated management and care delivery platform for LatAM healthcare businesses to increase patient access and engagement. It most recently raised $11.2 million from eight investors, led by Global Founders Capital and Upload Ventures, in a Series A round in January 2022.
EnPlusOne Biosciences, 2022
MBA Founder: Daniel Ahlstedt, Harvard Business School
Total Raised: $12 million
Latest Funding Round: $11.9M Seed September 2022
EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics. Northpond Ventures led its Seed funding round last September.
Ahlstedt, MBA ‘21, is co-founder, COO and board director. He met the scientific co-founders of EnPlusOne through participation in the Nucleate Program at Harvard. During this experience, Dan became convinced EnPlusOne had the technology and team to tackle the many problems facing RNA synthesis.
He was Blavatnik Fellow in Life Science Entrepreneurship which provided resources and mentorship instrumental in founding EnPlusOne.
SiteRx, 2019
MBA Founder: Seth Goodman, Columbia Business School
Total Raised: $10 million
Latest Funding Round: Undisclosed
SiteRx is a digital platform that instantly connects doctors and patients to clinical trials in their communities. It researches clinical trials to make it easier for doctors to connect patients to ground-breaking treatments they may otherwise not have access to. Its venture round in 2021 raised an undisclosed amount, led by Cofound Partners, according to Crunchbase.com.
“My father has dedicated his life to Alzheimer’s disease care and research. Watching my father tirelessly work day in and day out with Alzheimer’s patients and their families – and choosing to devote nearly all of his time outside of the clinic to find a cure – made me realize that I had to be part of the solution,” Goodman told Poets&Quants in 2019 when SiteRx was chosen as one of our Most Disruptive Startups of the year.
Goodman pursued an MBA at Columbia Business School in order to build SiteRx and to learn as much as he could about entrepreneurship, technology, and healthcare. He is founding member of the Graduate Entrepreneurship Council – a graduate network of entrepreneurs across CBS, HBS, Wharton, MIT, and Kellogg – and worked closely with Columbia’s Lang Center (which invested $100,000 into the company), Healthcare and Pharmaceutical Management Program, and Columbia Startup Lab.
“Columbia Business School Greenhouse Program, led by Dave Lerner and Brendan Burns, provided the critical launchpad for my business during the last semester of my program,” he told Poets&Quants.
NEXT PAGE: MBA Healthcare Startups Hey Jane and AAVRANI
Questions about this article? Email us or leave a comment below.